1. Home
  2. AREN vs CERS Comparison

AREN vs CERS Comparison

Compare AREN & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AREN
  • CERS
  • Stock Information
  • Founded
  • AREN 2016
  • CERS 1991
  • Country
  • AREN United States
  • CERS United States
  • Employees
  • AREN N/A
  • CERS N/A
  • Industry
  • AREN Medical/Dental Instruments
  • CERS EDP Services
  • Sector
  • AREN Health Care
  • CERS Technology
  • Exchange
  • AREN Nasdaq
  • CERS Nasdaq
  • Market Cap
  • AREN 305.8M
  • CERS 265.7M
  • IPO Year
  • AREN N/A
  • CERS 1997
  • Fundamental
  • Price
  • AREN $6.60
  • CERS $1.27
  • Analyst Decision
  • AREN Strong Buy
  • CERS Strong Buy
  • Analyst Count
  • AREN 1
  • CERS 2
  • Target Price
  • AREN $10.00
  • CERS $3.50
  • AVG Volume (30 Days)
  • AREN 185.1K
  • CERS 896.8K
  • Earning Date
  • AREN 08-18-2025
  • CERS 08-05-2025
  • Dividend Yield
  • AREN N/A
  • CERS N/A
  • EPS Growth
  • AREN N/A
  • CERS N/A
  • EPS
  • AREN 0.16
  • CERS N/A
  • Revenue
  • AREN $128,781,000.00
  • CERS $185,144,000.00
  • Revenue This Year
  • AREN $31.49
  • CERS $24.95
  • Revenue Next Year
  • AREN $10.00
  • CERS $11.88
  • P/E Ratio
  • AREN $30.46
  • CERS N/A
  • Revenue Growth
  • AREN N/A
  • CERS 13.06
  • 52 Week Low
  • AREN $0.56
  • CERS $1.12
  • 52 Week High
  • AREN $10.05
  • CERS $2.54
  • Technical
  • Relative Strength Index (RSI)
  • AREN 57.81
  • CERS 39.38
  • Support Level
  • AREN $5.62
  • CERS $1.34
  • Resistance Level
  • AREN $6.57
  • CERS $1.41
  • Average True Range (ATR)
  • AREN 0.54
  • CERS 0.07
  • MACD
  • AREN 0.04
  • CERS -0.02
  • Stochastic Oscillator
  • AREN 78.12
  • CERS 6.67

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: